| Ident. | Authors (with country if any) | Title |
|---|
| 000102 |
Hélène Pouclet [France] ; Pascal Derkinderen [France] ; Thibaud Lebouvier [France] | Foot dystonia heralding levodopa-induced dyskinesias in Parkinson disease |
| 000202 |
Fabrice Billet [France] ; Jean Costentin [France] ; Nathalie Dourmap [France] | Influence of corticostriatal δ-opioid receptors on abnormal involuntary movements induced by L-DOPA in hemiparkinsonian rats |
| 000234 |
Asha Kishore [Inde] ; Traian Popa [France] ; Balu Velayudhan [Inde] ; Thomas Joseph [Inde] ; Ammu Balachandran [Inde] ; Sabine Meunier [France] | Acute dopamine boost has a negative effect on plasticity of the primary motor cortex in advanced Parkinson's disease |
| 000239 |
Olivier Rascol [France] ; Joaquim Ferreira [Portugal] ; Laurence Negre-Pages [France] ; Santiago Perez-Lloret [France] ; Lucette Lacomblez [France] ; Monique Galitzky [France] ; Jean-Christophe Lemarie [France] ; Jean-Christophe Corvol [France] ; Jonathan M. Brotchie [Canada] ; Laura Bossi [France] | A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease |
| 000244 |
Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; QIN LI [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France] | A Critique of Available Scales and Presentation of the Non-Human Primate Dyskinesia Rating Scale |
| 000311 |
Elaine Del-Bel [France] ; Fernando Eduardo Padovan-Neto [France] ; Rita Raisman-Vozarl [France] ; Marcio Lazzarini [France] | Role of Nitric Oxide in Motor Control: Implications for Parkinson's Disease Pathophysiology and Treatment |
| 000339 |
Imtiaz Ahmed [Royaume-Uni] ; Subrata K. Bose [Royaume-Uni] ; Nicola Pavese [Royaume-Uni] ; Anil Ramlackhansingh [Royaume-Uni] ; Federico Turkheimer [Royaume-Uni] ; Gary Hotton [Royaume-Uni] ; Alexander Hammers [Royaume-Uni, France] ; David J. Brooks [Royaume-Uni] | Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias |
| 000367 |
Brigitte Spinnewyn [France] ; Christelle Charnet [France] ; Sylvie Cornet [France] ; Veronique Roubert [France] ; Pierre-Etienne Chabrier [France] ; Michel Auguet [France] | An improved model to investigate the efficacy of antidyskinetic agents in hemiparkinsonian rats |
| 000385 |
P. Derkinderen [France] | Quelles pistes pharmacologiques non-dopaminergiques pour le traitement de la maladie de Parkinson ? |
| 000422 |
Erwan Bezard [France] | GRK6, une nouvelle piste thérapeutique pour diminuer les dyskinésies induites par la L-dopa |
| 000445 |
Carlo Colosimo [Italie] ; Pablo Martinez-Martin [Espagne] ; Giovanni Fabbrini [Italie] ; Robert A. Hauser [États-Unis] ; Marcelo Merello [Argentine] ; Janis Miyasaki [Canada] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis] | Task Force Report on Scales to Assess Dyskinesia in Parkinson's Disease: Critique and Recommendations |
| 000452 |
Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew J. Lees [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne] | Safety and Efficacy of Perampanel in Advanced Parkinson's Disease: A Randomized, Placebo-Controlled Study |
| 000479 |
Daniella Rylander [Suède] ; Martin Parent [Canada] ; Sean S. O'Sullivan [Royaume-Uni] ; Sandra Dovero [France] ; Andrew J. Lees [Royaume-Uni] ; Erwan Bezard [France] ; Laurent Descarries [Canada] ; M. Angela Cenci [Suède] | Maladaptive Plasticity of Serotonin Axon Terminals in Levodopa-Induced Dyskinesia |
| 000578 |
Olivier Berton [États-Unis] ; Céline Guigoni [France] ; QIN LI [France] ; Bernard H. Bioulac [France] ; Incarnation Aubert [France] ; Christian E. Gross [France] ; Ralph J. Dileone [États-Unis] ; Eric J. Nestler [États-Unis] ; Erwan Bezard [France, République populaire de Chine] | Striatal Overexpression of ΔJunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease |
| 000585 |
Clemence Simonin [France] ; M. Tir [France] ; D. Devos [France] ; A. Kreisler [France] ; K. Dujardin [France] ; J. Salleron [France] ; A. Delval [France] ; S. Blond [France] ; L. Defebvre [France] ; A. Destee [France] ; P. Krystkowiak [France] | Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon |
| 000587 |
Sébastien Montel [France] ; Anne-Marie Bonnet [France] ; Catherine Bungener [France] | Quality of Life in Relation to Mood, Coping Strategies, and Dyskinesia in Parkinson's Disease |
| 000640 |
Caroline Moreau [France] ; Alain Destée [France] ; T. Foltynie [Royaume-Uni] ; B. Cheeran [Royaume-Uni] ; C. H. Williams-Gray [Royaume-Uni] ; M. J. Edwards [Royaume-Uni] ; S. A. Schneider [Royaume-Uni] ; D. Weinberger [États-Unis] ; J. C. Rothwell [Royaume-Uni] ; R. A. Barker [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] | BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease. Commentary |
| 000645 |
Stefan Schuster [Allemagne] ; Evelyne Doudnikoff [France] ; Daniella Rylander [Suède] ; Amandine Berthet [France] ; Incarnation Aubert [France] ; Carina Ittrich [Allemagne] ; Bertrand Bloch [France] ; M. Angela Cenci [Suède] ; D. James Surmeier [États-Unis] ; Bastian Hengerer [Allemagne] ; Erwan Bezard [France] | Antagonizing L-type Ca2+ Channel Reduces Development of Abnormal Involuntary Movement in the Rat Model of L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia |
| 000718 |
Anthony P. Nicholas [États-Unis] ; Farah D. Lubin [États-Unis] ; Penelope J. Hallett [États-Unis] ; Padmapriya Vattem [États-Unis] ; Paula Ravenscroft [Royaume-Uni] ; Erwan Bezard [France] ; SHAOBO ZHOU [Royaume-Uni] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] ; J. David Sweatt [États-Unis] ; David G. Standaert [États-Unis] | Striatal histone modifications in models of levodopa-induced dyskinesia |
| 000729 |
Christopher G. Goetz [États-Unis] ; Eugene Laska [États-Unis] ; Christine Hicking [Allemagne] ; Philippe Damier [France] ; Thomas Müller [Allemagne] ; John Nutt [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne] | Placebo Influences on Dyskinesia in Parkinson's Disease |
| 000757 |
S. Lesage [France] ; S. Belarbi [France] ; A. Troiano [France] ; C. Condroyer [France] ; N. Hecham [France] ; P. Pollak [France] ; E. Lohman [France] ; T. Benhassine [France, Algérie] ; F. Ysmail-Dahlouk [France] ; A. Dürr [France] ; M. Tazir [France] ; A. Brice [France] | IS THE COMMON LRRK2 G2019S MUTATION RELATED TO DYSKINESIAS IN NORTH AFRICAN PARKINSON DISEASE? |
| 000762 |
Valérie Fraix [France] ; Pierre Pollak [France] ; Laurent Vercueil [France] ; Alim-Louis Benabid [France] ; Francois Mauguiere [France] | Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's disease |
| 000766 |
I. Rektorova [République tchèque] ; S. Sedlackova [République tchèque] ; S. Telecka [République tchèque] ; A. Hlubocky [République tchèque] ; I. Rektor [République tchèque] | Dorsolateral Prefrontal Cortex : A Possible Target for Modulating Dyskinesias in Parkinson's Disease by Repetitive Transcranial Magnetic Stimulation |
| 000775 |
Dieter Scheller [Allemagne] ; Nick Dürrafiller [France] ; Paul Moser [France] ; Roger D. Porsolt [France] | Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the rat |
| 000778 |
Ana Munoz [Suède] ; QIN LI [République populaire de Chine] ; Fabrizio Gardoni [Italie] ; Elena Marcello [Italie] ; CHUAN QIN [République populaire de Chine] ; Thomas Carlsson [Suède] ; Deniz Kirik [Suède] ; Monica Di Luca [Italie] ; Anders Björklund [Suède] ; Erwan Bezard [France] ; Manolo Carta [Suède] | Combined 5-HTjA and 5-HTjB receptor agonists for the treatment of L-DOPA-induced dyskinesia |
| 000844 |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten-Year Follow-Up of Parkinson's Disease Patients Randomized to Initial Therapy with Ropinirole or Levodopa |
| 000853 |
Christopher G. Goetz [États-Unis] ; Philippe Damier [France] ; Christine Hicking [Allemagne] ; Eugene Laska [États-Unis] ; Thomas Müller [Allemagne] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne] | Sarizotan as a treatment for dyskinesias in Parkinson's disease : A double-blind placebo-controlled trial |
| 000860 |
Vincent Paille [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias |
| 000930 |
J.-C. Corvol [France] ; J.-A. Girault [France] ; D. Herve [France] | Rôle et régulation du récepteur D1 de la dopamine dans le striatum : implications dans les dyskinésies de la maladie de Parkinson |
| 000983 |
Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lledo [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne] | Pergolide versus levodopa monotherapy in early Parkinson's disease patients : The PELMOPET study |
| 000A14 |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5-year trial of ropinirole and L-dopa |
| 000A27 |
Servane Mouton [France] ; Jing Xie-Brustolin [France] ; Patrick Mertens [France] ; Gustavo Polo [France] ; Philippe Damier [France] ; Emmanuel Broussolle [France] ; Stéphane Thobois [France] | Chorea induced by globus pallidus externus stimulation in a dystonic patient |
| 000A33 |
Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France] | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets : Mediation by D2, not D3, dopamine receptors |
| 000A35 |
Naomi P. Visanji [Canada] ; Mark J. Millan [France] ; Jonathan M. Brotchie [Canada] | Actions at sites other than D3 receptors mediate the effects of BP897 on L-DOPA-induced hyperactivity in monoamine-depleted rats |
| 000B13 |
Incarnation Aubert [France] ; Céline Guigoni [France] ; Kerstin Hakansson [Suède] ; QIN LI [République populaire de Chine] ; Sandra Dovero [France] ; Nicole Barthe [France] ; Bernard H. Bioulac [France] ; Christian E. Gross [France] ; Gilberto Fisone [Suède] ; Bertrand Bloch [France] ; Erwan Bezard [France] | Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia |
| 000B42 |
Véronique Sgambato-Faure [France] ; Virginie Buggia [France] ; Frangois Gilbert [Canada] ; Daniel Levesque [Canada] ; Alim-Louis Benabid [France] ; Francois Berger [France] | Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-lnduced behavioral sensitization in dyskinetic rats |
| 000B56 |
Tatiana Witjas [France] ; Christelle Baunez [France] ; Jean Marc Henry [France] ; Marie Delfini [France] ; Jean Regis [France] ; André Ali Cherif [France] ; Jean Claude Peragut [France] ; Jean Philippe Azulay [France] | Addiction in Parkinson's disease : Impact of subthalamic nucleus deep brain stimulation |
| 000B77 |
Luc Defebvre [France] | Les complications motrices de la dopathérapie chez le malade parkinsonien: sémiologie clinique et modalités d'évaluation |
| 000B84 |
J.-P. Nguyen [France] | Greffe neuronale dans le traitement de la maladie de Parkinson : Mise au point et perspectives d'avenir |
| 000C12 |
M. A. Silverdale [Royaume-Uni] ; S. L. Nicholson [Royaume-Uni] ; P. Ravenscroft [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; M. J. Millan [France] ; J. M. Brotchie [Canada] | Selective blockade of D3 dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate |
| 000C14 |
Paula Ravenscroft [Royaume-Uni] ; Sylvie Chalon [France] ; Jonathan M. Brotchie [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] | Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia |
| 000C15 |
Vincent Paille [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease |
| 000C34 |
Erwan Bezard [France] ; Michael P. Hill [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Anne Michel [Belgique] ; Renee Grimee [Belgique] ; Henrik Klitgaard [Belgique] | Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque |
| 000C63 |
F. Durif [France] ; B. Debilly [France] ; M. Galitzky [France] ; D. Morand [France] ; F. Viallet [France] ; M. Borg [France] ; S. Thobois [France] ; E. Broussolle [France] ; O. Rascol [France] | Clozapine improves dyskinesias in Parkinson disease: A double-blind, placebo-controlled study |
| 000D01 |
Michel Bonduelle [France] ; Jean Cambier | Le corps de Luys |
| 000D51 |
Christian E. Gross [France] ; Paula Ravenscroft [France] ; Sandra Dovero [France] ; Mohamed Jaber [France] ; Bernard Bioulac [France] ; Erwan Bezard [France] | Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice |
| 000D54 |
Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimee [Belgique] ; Henrik Klitgaard [Belgique] | Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset |
| 000E04 |
Olivier Guillin [France] ; Nathalie Griffon [France] ; Erwan Bezard [France] ; Ludovic Leriche [France] ; Jorge Diaz [France] ; Christian Gross [France] ; Pierre Sokoloff [France] | Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease |
| 000E10 |
C. Chassain [France] ; A. Eschalier [France] ; F. Durif [France] | Antidyskinetic effect of magnesium sulfate in MPTP-lesioned monkeys |
| 000E28 |
A. Destee [France] ; R. Bordet [France] | Stimulation dopaminergique continue, stimulation dopaminergique pulsatile |
| 000E33 |
O. Rascol [France] ; J.-J. Ferreira [Portugal] ; P. Payoux [France] ; Ch. Brefel-Courbon [France] ; J.-L. Montastruc [France] | Prise en charge des dyskinésies par la lévodopa |
| 000E36 |
F. Viallet [France] ; T. Witjas [France] | Neuroplasticité et maladie de Parkinson |
| 000E42 |
| Maladie de Parkinson |
| 000E46 |
A. Nieoullon [France] ; M. Amalric [France] | Les récepteurs dopaminergiques : aspects structuraux et implications fonctionnelles |
| 000E49 |
A.-M. Bonnet [France] ; J.-L. Houeto [France] | Le pergolide: un agoniste utile dans le traitement de la maladie de Parkinson |
| 000E64 |
P. Derkinderen [France] ; M. Vidailhet [France] | Dyskinésies provoquées par la L-DOPA |
| 000E92 |
Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Repeated administration of Piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: A behavioural and biochemical investigation |
| 001045 |
Paul Krack [France, Allemagne] ; Rajeev Kumar [États-Unis] ; Claire Ardouin [France] ; Patricia Limousin Dowsey [Royaume-Uni] ; John M. Mcvicker [France, États-Unis] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Mirthful laughter induced by subthalamic nucleus stimulation |
| 001060 |
O. Rascol [France] ; J. G. Nutt [États-Unis] ; O. Blin [France] ; C. G. Goetz [États-Unis] ; J. M. Trugman [États-Unis] ; C. Soubrouillard [France] ; J. H. Carter [États-Unis] ; L. J. Currie [États-Unis] ; N. Fabre [France] ; C. Thalamas [France] ; W. J. Giardina [États-Unis] ; S. Wright [États-Unis] | Induction by Dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with parkinson Disease |
| 001064 |
O. Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France] | Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease |
| 001077 |
Olivier Rascol [France] ; Nelly Fabre [France] | Dyskinesia: L-dopa-induced and tardive dyskinesia |
| 001080 |
Thomas Boraud [France] ; Erwan Bezard [France] ; Bernard Bioulac [France] ; Christian E. Gross [France] | Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey |
| 001111 |
M. H. Marion [Royaume-Uni] | Traitement médicamenteux des complications motrices à un stade évolué de la maladie de Parkinson |
| 001155 |
P. Damier [France] ; L. Tramblay [France] ; J. Feger [France] ; E. C. Hirsch [France] | Développement des dyskinésies provoquées par le traitement de la maladie de Parkinson : rôle de la première exposition à la L-DOPA (ou phénomène du « priming ») |
| 001176 |
O. Rascol [France] | The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease |
| 001189 |
E. C. Hirsch [France] ; BENABID ; OLANOW ; SEALFON ; HALLETT ; LANGSTON ; CALABRESI | Nigrostriatal system plasticity in Parkinson's disease : Effect of dopaminergic denervation and treatment. Discussion |
| 001196 |
O. Rascol [France] | Medical treatment of levodopa-induced dyskinesias |
| 001200 |
B.-P. Bejjani [France, Liban] ; I. Arnulf [France] ; S. Demeret [France] ; P. Damier [France] ; A.-M. Bonnet [France] ; J.-L. Houeto [France] ; Yves Agid [France] | Levodopa-induced dyskinesias in Parkinson's disease : Is sensitization reversible? |
| 001221 |
T. Boraud [France] ; E. Bezard [France] ; J. M. Stutzmann [France] ; B. Bioulac [France] ; C. E. Gross [France] | Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey |
| 001225 |
A. L. Benabid [France] ; A. Benazzouz [France] ; P. Limousin [France] ; A. Koudsie [France] ; P. Krack [Allemagne] ; B. Piallat [France] ; P. Pollak [France] | Dyskinesias and the subthalamic nucleus |
| 001231 |
C. Warren Olanow [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] | Continuous dopamine-receptor stimulation in early Parkinson's disease |
| 001248 |
O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; A. D. Korczyn [Israël] ; P. P. De Deyn [Belgique] ; C. E. Clarke [Royaume-Uni] ; A. E. Lang [Canada] | A five-year study of the incidence of dyskinesia in patients with early parkinson's disease who were treated with ropinirole or levodopa |
| 001278 |
D. Caparros-Lefebvre ; P. Pollak [France] ; M. P. Feltin [France] ; S. Blond [France] ; A. L. Benabid [France] | Effet de la stimulation thalamique sur les dyskinésies induites par la L-dopa : évaluation d'une cible nouvelle : Le centre médian parafasciculaire |
| 001284 |
E. Broussolle [France] | Arguments en faveur du traitement initial de la maladie de Parkinson par la L-dopa |
| 001287 |
F. Durif [France] ; M. Vidailhet [France] ; B. Debilly [France] ; Yves Agid [France] | Worsening of levodopa-induced dyskinesias by motor and mental tasks |
| 001297 |
M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi [France] ; F. Durif [France] ; Yves Agid [France] | The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease |
| 001308 |
C. G. Goetz [États-Unis] | Rating scales for dyskinesias in Parkinson's disease |
| 001333 |
D. Caparros-Lefebvre [France] ; S. Blond [France] ; M.-P. Feltin [France] ; P. Pollak [France] ; A. L. Benabid [France] | Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement : possible involvement of the centre median and parafascicularis complex |
| 001339 |
P. Krack [France, Allemagne] ; P. Pollak [France] ; P. Limousin [France, Royaume-Uni] ; A. Benazzouz [France] ; G. Deuschl [Allemagne] ; A.-L. Benabid [France] | From off-period dystonia to peak-dose chorea : The clinical spectrum of varying subthalamic nucleus activity |
| 001348 |
P. Damier [France] ; C. Jaillon [France] ; I. Clavier [France] ; I. Arnulf [France] ; A.-M. Bonnet [France] ; B.-P. Bejjani [France] ; Yves Agid [France] | Dyskinesias assessment in phase II studies |
| 001349 |
P. Brown [Royaume-Uni] ; A. Manson [Royaume-Uni] | Dyskinesias assessment and ambulatory devices |
| 001350 |
H. Widner [Suède] ; G.-L. Defer [France] | Dyskinesias assessment : From CAPIT to CAPSIT |
| 001366 |
F. Durif [France] ; J.-J. Lemaire [France] ; B. Debilly [France] ; G. Dordain [France] | Acute and chronic effects of anteromedial globus pallidus stimulation in Parkinson's disease |
| 001386 |
O. Rascol [France] ; C. Brefel-Courbon [France] ; O. Blin [France] | Pharmacologie clinique des dyskinésies induites par la L-dopa chez les malades parkinsoniens |
| 001429 |
P. Krack [France] ; P. Pollak [France] ; P. Limousin [France] ; D. Hoffmann [France] ; A. Benazzouz [France] ; J. F. Le Bas [France] ; A. Koudsie [France] ; A. L. Benabid [France] | Opposite motor effects of pallidal stimulation in Parkinson's disease |
| 001442 |
P. Krack [France] ; P. Pollak [France] ; P. Limousin [France] ; D. Hoffmann [France] ; A. Benazzouz [France] ; A.-L. Benabid [France] | Inhibition of levodopa effects by internal pallidal stimulation |
| 001461 |
O. Rascol [France] ; U. Sabatini [France, Italie] ; C. Brefel [France] ; N. Fabre [France] ; S. Rai [France] ; J. M. Senard [France] ; P. Celsis [France] ; G. Viallard [France] ; J. L. Montastruc [France] ; F. Chollet [France] | Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia |
| 001529 |
M. Vidailhet [France] | Dyskinésies provoquées par la L-dopa : Maladie de Parkinson - 2e partie |
| 001559 |
B. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; A. M. Bonnet [France] ; M. Vidailhet [France] ; D. Dormont [France] ; B. Pidoux [France] ; P. Cornu [France] ; C. Marsault [France] ; Yves Agid [France] | Pallidal stimulation for Parkinson's disease : Two targets? |
| 001567 |
F. Durif [France] ; M. Vidailhet [France] ; F. Assal [France] ; C. Roche [France] ; A. M. Bonnet [France] ; Yves Agid [France] | Low-dose clozapine improves dyskinesias in Parkinson's disease |
| 001574 |
C. Gross [France] ; A. Rougier ; D. Guehl ; T. Boraud ; J. Julien ; B. Bioulac | High-frequency stimulation of the globus pallidus internalis in Parkinson's disease : a study of seven cases |
| 001587 |
P. Krack [Allemagne] ; P. Limousin [France] ; A. L. Benabid [France] ; P. Pollak [France] | Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease |
| 001649 |
A. F. Carpentier [France] ; A. M. Bonnet [France] ; M. Vidailhet [France] ; Yves Agid [France] | Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease |
| 001654 |
M. T. Herrero [Espagne] ; S. J. Augood [Royaume-Uni] ; H. Asensi [Espagne] ; E. C. Hirsch [France] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. Emson [Royaume-Uni] | Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys |
| 001723 |
F. Durif [France] ; M. Vidailhet ; A. M. Bonnet ; J. Blin ; Yves Agid [France] | Levodopa-induced dyskinesias are improved by fluoxetine |
| 001797 |
R. Marconi [France] ; D. Lefebvre-Caparros ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; B. Dubois [France] ; Yves Agid [France] | Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology |
| 001806 |
M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi ; N. Gouider-Khouja ; Y. Agig [France] | Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot ? |
| 001809 |
I. Jalenques [France] ; A.-J. Coudert | Clozapine for the treatment of levodopa-induced psychosis and dyskinesia in Parkinson's disease |
| 001894 |
D. Caparros-Lefebvre [France] ; S. Blond [France] ; P. Vermersch [France] ; N. Pecheux [France] ; J.-D. Guieu [France] ; H. Petit [France] | Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease |
| 001A98 |
E. Pourcher ; A.-M. Bonnet ; J. Kefalos ; B. Dubois ; Yves Agid [France] | Effects of etybenzatropine and diazepam on Levodopa-induced diphasic dyskinesias in Parkinson's disease |
| 001B19 |
C. Sereni | Complications extra-pyramidales des neuroleptiques |
| 001B33 |
B. Gueguen | Un parkinsonien qui se bloque |
| 001B47 |
A. Devaux | Dyskinésies tardives: rôle de la pyridoxine dans la prévention |
| 001B51 |
M. Ziegler ; V. Fournier ; N. Bathien ; P. L. Morselli ; P. Rondot | Therapeutic response to progabide in neuroleptic- and L-DOPA-induced dyskinesias |
